Global Pharmaceutical Manufacturing Market Insights 2029: Drivers, Challenges, and Revenue Forecast
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What CAGR And Valuation Are Anticipated For The Pharmaceutical Manufacturing Market?
In previous years, there’s been a rapid expansion in the size of the pharmaceutical manufacturing market. It’s projected to increase from $519.78 billion in 2024 to $572.33 billion in 2025, representing a compound annual growth rate (CAGR) of 10.1%. The historical growth can be linked to a rise in global disease prevalence, increased spending on healthcare, a growing demand for generic drugs, the expiry of patents on top-selling drugs, and an enlargement in pharmaceutical production capacity.
The market size of pharmaceutical manufacturing is anticipated to experience considerable expansion in the forthcoming years, projected to reach $841.14 billion by 2029 with a compound annual growth rate (CAGR) of 10.1%. Factors driving this projected growth during the forecast period include expansion of personalized medicine, a growing elderly population, increasing demand for biosimilars, governmental backing for domestic manufacturing, and a surge in chronic disease occurrence. Key trends expected during the forecast period involve progress in continuous manufacturing, the integration of artificial intelligence, adoption of smart manufacturing technologies, groundbreaking advances in biologics production and an emphasis on research and development efficiency.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24375&type=smp
What Market Forces Are Contributing To The Growth Of The Pharmaceutical Manufacturing Market?
The rise in chronic health conditions is anticipated to stimulate growth in the pharmaceutical manufacturing industry. Chronic diseases, which generally progress gradually and persist for over a year, often necessitate continuous medical care or limit daily activities. The escalation in these conditions can be attributed to increasing life expectancy, inactive lifestyles, and poor dietary habits, which contribute to a higher demand for long-term healthcare options and preventive wellness strategies. The pharmaceutical manufacturing industry plays a pivotal role in combating these diseases by ensuring an uninterrupted supply of indispensable medicines, fostering innovation in drug creation, and fulfilling the escalating demand for efficient, long-lasting treatment solutions. For example, in September 2024, the National Health Service in the UK reported that 11% of adults aged 35 and older are diagnosed with severe chronic kidney disease, with the incidence and intensity increasing with age. Approximately 48% of individuals aged 75 and older have some form of the disease, and 36% are in more severe stages. Consequently, the growing incidence of chronic diseases is propelling growth in the pharmaceutical manufacturing sector.
Which Segmentation Factors Are Critical In The Pharmaceutical Manufacturing Market Analysis?
The pharmaceutical manufacturingmarket covered in this report is segmented –
1) By Molecule Type: Biologics And Biosimilars; Conventional Drugs
2) By Formulation: Tablets; Capsules; Injectable; Sprays; Suspensions; Powders; Other Formulations
3) By Route Of Administration: Oral; Topical; Parenteral; Inhalations; Other Route Of Administrations
4) By Therapy Area: Cardiovascular Diseases (CVDs); Pain; Diabetes; Cancer; Respiratory Diseases; Other Diseases
5) By Sales Channel: Retail; Non-retail
Subsegments:
1) By Biologics And Biosimilars: Monoclonal Antibodies; Vaccines; Recombinant Proteins; Cell Therapies; Gene Therapies; Hormones; Blood And Plasma Products
2) By Conventional Drugs: Analgesics; Antipyretics; Antibiotics; Antivirals; Antifungals; Antihypertensives; Antidepressants; Antidiabetics
How Are Global Trends Impacting The Development Of The Pharmaceutical Manufacturing Market?
Top pharmaceutical manufacturing companies are driving efforts towards creating advanced solutions like fully automated RLT production facilities to maintain optimum production efficiency, guarantee high-quality standards, and fulfill the escalating need for specific cancer treatments. Automated RLT production sites represent cutting-edge manufacturing locations that utilize innovative automation technology to enhance and perfect the production of radioligand treatments, ensuring reliable, economical, and scalable manufacturing. For example, in January 2024, the Switzerland-based Novartis AG obtained US FDA approval for developing Pluvicto at an ultramodern radioligand therapy (RLT) manufacturing facility in Indianapolis, thereby significantly augmenting production capability for its radioligand therapy medications, like Pluvicto and Lutathera. This development forms a crucial part of Novartis’ wider strategy to cater to the exponentially growing global demand for specific cancer treatments and boost accessibility for patients globally.
Which Organizations Are At The Forefront Of The Pharmaceutical Manufacturing Market?
Major companies operating in the pharmaceutical manufacturing market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories, Cipla Limited, Samsung Biologics, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Lupin Limited, Jubilant Pharmova Limited.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-manufacturing-global-market-report
Which Region Is Leading Innovation In The Pharmaceutical Manufacturing Market?
North America was the largest region in the pharmaceutical manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=24375&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Manufacturing Market 2025, By The Business Research Company
Companion Animal Pharmaceuticals Global Market Report 2025
Ethical Pharmaceuticals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ethical-pharmaceuticals-global-market-report
Biopharmaceuticals Contract Manufacturing Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
